About the company

Phialogics is an innovative start-up in the field of autoimmune diseases. Founded in 2021 by a team of widely recognized experts in protein engineering and immunology, the company based in Basel (CH) and Heidelberg (GER) is committed to making a decisive contribution to the autoimmune disease space. The founding team is backed by strong Scientific Advisory and Supervisory Boards, which puts the company in a good position to move fast on the lead candidate and develop novel biologics.

Do you want to

know more about this company?

Zum Artikel

Dr. Katharina Severin Investment Manager

Dr. Katharina SeverinInvestment Manager

Phialogics in the news

Zum Artikel

News

19. April 2023

Phialogics secures pre-seed financing for Next-Gen IgV Therapeutics to modulate immune responses in inflammatory diseases

More startups from Life Sciences